Overview

Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation

Status:
Terminated

Trial end date:
2014-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to describe the kinetics of lymphocyte subsets reconstitution after growth factor administration, Pegfilgrastim versus Filgrastim in patients with B-cell malignant non-Hodgkin lymphoma treated with high-dose chemotherapy and autologous peripheral stem cell transplantation.

Phase:

N/A

Details

Lead Sponsor:

Centre Leon Berard

Collaborator:

Amgen

Treatments:

Lenograstim